Literature DB >> 14987428

A2 (N-benzylpiperazine) a new drug of abuse in Sweden.

Maria Wikström1, Per Holmgren, Johan Ahlner.   

Abstract

N-Benzylpiperazine was tested in the beginning of the 1970s as a possible antidepressant drug. However, in both animal and human studies, it was shown to possess amphetamine-like properties, and any further studies were stopped. In a forensic autopsy case in 1999, we found a substance so far unknown to us in the chromatogram of our method used for amphetamines. We could swiftly identify this compound as N-benzylpiperazine because of information given to us by a newly formed network comprising, among others, customs and the police. Since then, we have found N-benzylpiperazine in several cases, among them 11 cases from a number of prisons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14987428     DOI: 10.1093/jat/28.1.67

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

Review 1.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

2.  A deep-learning system bridging molecule structure and biomedical text with comprehension comparable to human professionals.

Authors:  Zheni Zeng; Yuan Yao; Zhiyuan Liu; Maosong Sun
Journal:  Nat Commun       Date:  2022-02-14       Impact factor: 14.919

Review 3.  NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches.

Authors:  Giorgia Vaccaro; Anna Massariol; Amira Guirguis; Stewart B Kirton; Jacqueline L Stair
Journal:  Drug Test Anal       Date:  2022-04-20       Impact factor: 3.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.